ELISA (enzyme-linked immunosorbent assay) is a plaque-based assay technique designed to detect and quantify substances such as peptides, proteins, antibodies and hormones.

The indirect ELISA is for the detection of antibodies directed against avian infectious laryngotracheitis virus (ILTV) in vaccinated and / or infected chicken sera. The characteristics of this product are as follows:

– High specificity and analytical sensitivity
– Comprehensive data analysis with the IDSoft ™ program
– Freeze-dried positive and negative reference sera available as internal controls
– The stop solution no longer contains H2SO4, which means that it is less corrosive


The company ID.Vet France has started the commercialization of a new kit that evaluates the antibodies against the gl protein of the virus ILT included in the recombinant vaccines for broilers. Compared to other commercial kits, there is a significant difference in the detection of seropositive animals with our new ID Screen® gI ILT Indirect diagnostic kit.

According to studies carried out by the company INNOVAX Vaccination against ILT is common in the poultry industry. Measurement of the serological response 3-4 weeks post vaccination is common practice in many countries. With the introduction of the new type of vector vaccines the question was whether a similar response could be measured compared to the conventional type of ILT vaccines available in ILT kits from Elisa.

Facing the results of the studies and tests of the new ID Screen® gI ILT Indirect diagnostic kit against other commercial kits shows the great difference in detection of sero-reactive animals between conventional kits and our new vaccine specific kit Recombinant.

The results can be seen below in two tables below, which belong to a recent research work done by MSD. The results can be seen in the following tabs, which were part of a recent research conducted by MSD.



Elisa titer response post CEO ILT vaccine
in conventional and gI Elisa showed high level of positive
response 5 wks post vaccination
CEO ILT                gI ILT Elisa           Synbiotics Elisa
85%                       100%

As we have seen, once again, the technical quality and capacity of the company that we proudly represent in Central America is demonstrated once again to interpret the needs of our consumers.

For more information, request samples or to purchase the kit, please contact us at gerencialatam@bioadvance.life